文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

纳米生物技术对抗抗菌药物耐药性:利用纳米尺度材料和技术的力量。

Nanobiotics against antimicrobial resistance: harnessing the power of nanoscale materials and technologies.

机构信息

Department of Chemistry, University of Delhi, New Delhi, 110007, India.

Department of Immunology and Infectious Disease Biology, CSIR-Institute of Genomics and Integrative Biology, Sukhdev Vihar, New Delhi, 110025, India.

出版信息

J Nanobiotechnology. 2022 Aug 12;20(1):375. doi: 10.1186/s12951-022-01573-9.


DOI:10.1186/s12951-022-01573-9
PMID:35953826
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9371964/
Abstract

Given the spasmodic increment in antimicrobial resistance (AMR), world is on the verge of "post-antibiotic era". It is anticipated that current SARS-CoV2 pandemic would worsen the situation in future, mainly due to the lack of new/next generation of antimicrobials. In this context, nanoscale materials with antimicrobial potential have a great promise to treat deadly pathogens. These functional materials are uniquely positioned to effectively interfere with the bacterial systems and augment biofilm penetration. Most importantly, the core substance, surface chemistry, shape, and size of nanomaterials define their efficacy while avoiding the development of AMR. Here, we review the mechanisms of AMR and emerging applications of nanoscale functional materials as an excellent substitute for conventional antibiotics. We discuss the potential, promises, challenges and prospects of nanobiotics to combat AMR.

摘要

鉴于抗菌药物耐药性(AMR)的间歇性增长,世界正处于“后抗生素时代”的边缘。预计当前的 SARS-CoV2 大流行将在未来使情况恶化,主要是由于缺乏新一代的抗菌药物。在这种情况下,具有抗菌潜力的纳米材料有望成为治疗致命病原体的有效手段。这些功能材料具有独特的优势,可以有效地干扰细菌系统并增强生物膜穿透性。最重要的是,纳米材料的核心物质、表面化学、形状和大小决定了它们的功效,同时避免了 AMR 的发展。在这里,我们回顾了 AMR 的机制以及纳米功能材料作为传统抗生素替代品的新兴应用。我们讨论了纳米抗生素对抗 AMR 的潜力、承诺、挑战和前景。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2b7/9373336/cf24214d4407/12951_2022_1573_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2b7/9373336/c48518a0c40d/12951_2022_1573_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2b7/9373336/f8b6a4889505/12951_2022_1573_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2b7/9373336/01a41e2ee8f2/12951_2022_1573_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2b7/9373336/cf24214d4407/12951_2022_1573_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2b7/9373336/c48518a0c40d/12951_2022_1573_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2b7/9373336/f8b6a4889505/12951_2022_1573_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2b7/9373336/01a41e2ee8f2/12951_2022_1573_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2b7/9373336/cf24214d4407/12951_2022_1573_Fig4_HTML.jpg

相似文献

[1]
Nanobiotics against antimicrobial resistance: harnessing the power of nanoscale materials and technologies.

J Nanobiotechnology. 2022-8-12

[2]
Coronavirus Disease 2019 and Antimicrobial Resistance: Parallel and Interacting Health Emergencies.

Clin Infect Dis. 2021-5-4

[3]
Antimicrobial Resistance in the COVID-19 Landscape: Is There an Opportunity for Anti-Infective Antibodies and Antimicrobial Peptides?

Front Immunol. 2022

[4]
Treatment of COVID-19: implications for antimicrobial resistance in Africa.

Pan Afr Med J. 2020-7-20

[5]
Plant synthetic biology for producing potent phyto-antimicrobials to combat antimicrobial resistance.

Biotechnol Adv. 2021

[6]
Antimicrobial Resistance Threats in the emerging COVID-19 pandemic: Where do we stand?

J Infect Public Health. 2021-5

[7]
Nanobiotics and the One Health Approach: Boosting the Fight against Antimicrobial Resistance at the Nanoscale.

Biomolecules. 2023-7-28

[8]
Addressing a future pandemic: how can non-biological complex drugs prepare us for antimicrobial resistance threats?

Mater Horiz. 2022-8-1

[9]
Prospects of Exploring the Metal-Organic Framework for Combating Antimicrobial Resistance.

ACS Appl Bio Mater. 2021-12-20

[10]
Harnessing Nanoparticles to Overcome Antimicrobial Resistance: Promises and Challenges.

Curr Pharm Des. 2025

引用本文的文献

[1]
Polysaccharide-Based Nanocarriers for Natural Antimicrobials: A Review.

Polymers (Basel). 2025-6-24

[2]
Based on quorum sensing: reverse effect of traditional Chinese medicine on bacterial drug resistance mechanism.

Front Cell Infect Microbiol. 2025-6-3

[3]
Impact of protein corona and light modulation on the antibacterial activity of light-activated silver nanoparticles.

J Mater Chem B. 2025-5-29

[4]
Combating Antibiotic Resistance: Mechanisms, Multidrug-Resistant Pathogens, and Novel Therapeutic Approaches: An Updated Review.

Pharmaceuticals (Basel). 2025-3-12

[5]
Treatment of lung diseases nanoparticles and nanorobots: Are these viable alternatives to overcome current treatments?

Mater Today Bio. 2025-2-26

[6]
Novel Approaches for Treatment of Intraoral Microbial Infections.

J Dent Res. 2025-6

[7]
Antibacterial Properties of Lemon Juice-Mediated Zinc Oxide Nanoparticle and Titanium Dioxide Nanoparticle.

J Pharm Bioallied Sci. 2024-12

[8]
A New Insight into Phage Combination Therapeutic Approaches Against Drug-Resistant Mixed Bacterial Infections.

Phage (New Rochelle). 2024-12-18

[9]
Gold Nanoparticles Functionalized With 5-Amino-2-Mercaptobenzimidazole: A Promising Antimicrobial Strategy Against Carbapenem-Resistant Gram-Negative Bacteria.

Int J Nanomedicine. 2025-2-27

[10]
Staphylococcal Drug Resistance: Mechanisms, Therapies, and Nanoparticle Interventions.

Infect Drug Resist. 2025-2-19

本文引用的文献

[1]
Biofilms and Their Role in Disease Pathogenesis.

Front Cell Infect Microbiol. 2022

[2]
Prevalence, risk factors, and molecular analysis of vancomycin-resistant Enterococci colonization in a referral neonatal intensive care unit: a prospective study in northern Iran.

J Glob Antimicrob Resist. 2022-9

[3]
Vaccination against Bacterial Infections: Challenges, Progress, and New Approaches with a Focus on Intracellular Bacteria.

Vaccines (Basel). 2022-5-10

[4]
Nanoparticles of Bioactive Metals/Metal Oxides and Their Nanocomposites with Antibacterial Drugs for Biomedical Applications.

Materials (Basel). 2022-5-18

[5]
Nanocarriers for combating biofilms: Advantages and challenges.

J Appl Microbiol. 2022-9

[6]
pH-Triggered Size-Tunable Silver Nanoparticles: Targeted Aggregation for Effective Bacterial Infection Therapy.

Small. 2022-6

[7]
Antibiotic resistance in the commensal human gut microbiota.

Curr Opin Microbiol. 2022-8

[8]
Progress Report: Antimicrobial Drug Discovery in the Resistance Era.

Pharmaceuticals (Basel). 2022-3-28

[9]
Biological Nanoparticles in Vaccine Development.

Front Bioeng Biotechnol. 2022-3-23

[10]
Recent Advances and Mechanistic Insights into Antibacterial Activity, Antibiofilm Activity, and Cytotoxicity of Silver Nanoparticles.

ACS Appl Bio Mater. 2022-4-18

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索